HPV vaccine plus cervical screening for women with HIV
Treatments studied
Part of Immune system & allergy, Infections clinical trials.
This trial tests whether adding HPV vaccination to the cervical cancer screening plan—while you get care at HIV (ARV) clinics—improves prevention of cervical problems. It focuses on women with HIV aged 25–35 to help reduce HPV-related cervical disease over time.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are a woman living with HIV
- You are between 25 and 35 years old
- You get care at an HIV treatment (ARV) clinic
- You are able to understand the study and consent (mentally able)
- You are not pregnant
- You are not less than 3 months after childbirth
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial compares two ways to help women with HIV get screened for cervical cancer: a clinic-based approach versus a combined clinic and community outreach program. You may be able to provide samples yourself at a clinic or at home to test for HPV, the virus that can cause cervical cancer.
This study compares two ways to screen women with HIV for cervical cancer: using a self-collection test at home versus visiting a clinic. The goal is to make cervical cancer screening easier and reach more women who might otherwise skip it.
This study looks at HPV infection and the natural balance of bacteria in the vagina in women with HIV. It aims to understand how these factors affect health and may guide future prevention or treatment.
This study tests whether a chemotherapy cream (5-fluorouracil) applied after heat treatment can better prevent cervical and anal precancers in women with HIV. The goal is to improve outcomes for women in Kenya who test positive for HPV, a virus that can cause cancer.
This study looks at how well the HPV vaccine works in women living with HIV and whether it helps make cervical cancer screening more accurate. If you are a woman with HIV between 21 and 40 years old and already part of certain other HIV studies, you may be able to join.
This trial tests a new way to prevent cervical cancer in women with both HIV and HPV. It focuses on women in India who are already on stable HIV treatment and have a normal cervical exam.
Hear when a new HPV Infection trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.